GLP1R and obesity due to melanocortin 4 receptor deficiency: By integrating findings from preclinical studies,randomized controlled trials, and meta-analyses, this review aims to provide acomprehensive understanding of the therapeutic potential of GLP-1 RAs in managinghypertension within the framework of diabetes and obesity care.